Teladoc Health, Inc.
TDOCFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2,570
Cost of Revenue
751
Gross Profit
1,818
Gross Margin
70.8%
Operating Income
-1,021
Operating Margin
-39.7%
Net Income
-1,001
Net Margin
-39.0%
EPS (Basic)
$-5.87
EPS (Diluted)
$-5.87
EBITDA
32
EBITDA Margin
1.2%
2023
12/31/2023
Revenue
2,602
Cost of Revenue
760
Gross Profit
1,842
Gross Margin
70.8%
Operating Income
-249
Operating Margin
-9.6%
Net Income
-220
Net Margin
-8.5%
EPS (Basic)
$-1.36
EPS (Diluted)
$-1.34
EBITDA
44
EBITDA Margin
1.7%
2022
12/31/2022
Revenue
2,407
Cost of Revenue
744
Gross Profit
1,663
Gross Margin
69.1%
Operating Income
-13,653
Operating Margin
-567.3%
Net Income
-13,660
Net Margin
-567.5%
EPS (Basic)
$-84.60
EPS (Diluted)
$-84.60
EBITDA
-8
EBITDA Margin
-0.3%
2021
12/31/2021
Revenue
2,033
Cost of Revenue
650
Gross Profit
1,382
Gross Margin
68.0%
Operating Income
-266
Operating Margin
-13.1%
Net Income
-429
Net Margin
-21.1%
EPS (Basic)
$-2.73
EPS (Diluted)
$-2.73
EBITDA
-31
EBITDA Margin
-1.5%
2020
12/31/2020
Revenue
1,094
Cost of Revenue
391
Gross Profit
703
Gross Margin
64.3%
Operating Income
-506
Operating Margin
-46.3%
Net Income
-485
Net Margin
-44.3%
EPS (Basic)
$-5.36
EPS (Diluted)
$-5.36
EBITDA
-354
EBITDA Margin
-32.4%